Zobrazeno 1 - 10
of 251
pro vyhledávání: '"Niparuck, P."'
Autor:
Natnai Charoonrochana, Natini Jinawath, Pitak Santanirand, Atisak Jiaranaikulwanich, Aruchalean Taweewongsounton, Chavachol Setthaudom, Tananun Tanpaibule, Dootsadeephorn Surin, Pansachee Damronglerd, Wasithep Limvorapitak, Sirapat Rungwittayatiwat, Subencha Pinsai, Pimjai Niparuck, Porpon Rotjanapan
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Universal antifungal treatment has been recommended among hematology patients during chemotherapy to prevent invasive aspergillosis (IA) in developed countries, but it remains a significant challenge in resource-limited settings. Identifying
Externí odkaz:
https://doaj.org/article/b8e609fb32f442e99a9c9dd2e8c4bb65
Autor:
Kochawan Boonyawat, Tichayapa Phojanasenee, Phichchapha Noikongdee, Pornnapa Police, Pichika Chantrathammachart, Pimjai Niparuck, Teeraya Puavilai, Angsana Phuphuakrat, Pantep Angchaisuksiri
Publikováno v:
Thrombosis Journal, Vol 21, Iss 1, Pp 1-7 (2023)
Abstract Background The prevalence of anti-platelet factor 4 (PF4)/polyanionic antibodies occurring after vaccination with ChAdOx1 nCoV-19 is low. Most of these antibodies are not associated with vaccine-induced thrombotic thrombocytopenia. It remain
Externí odkaz:
https://doaj.org/article/12c61d30b9a5445ca56fdcabc0dd7f04
Autor:
C. Polprasert, C. Chanswangphuwana, W. Owattanapanich, S. Kungwankiattichai, E. Rattarittamrong, T. Rattanathammethee, A. Tantiworawit, W. Limvorapitak, S. Saengboon, P. Niparuck, T. Puavilai, J. Julamanee, P. Saelue, C. Wanitpongpun, C. Nakhakes, K. Prayongratana, E. Karoopongse, P. Rojnuckarin, C. Sriswasdi
Publikováno v:
Leukemia Research Reports, Vol 21, Iss , Pp 100420- (2024)
Introduction: “AML with MECOM rearrangement” was recently categorized by WHO classification 2022 regardless of blast count, which included those present with MDS and AML into this group. We aim to explore frequency, clinical characteristics, and
Externí odkaz:
https://doaj.org/article/7634b614695542c792e16d388abd73b3
Autor:
Nittaya Limsuwanachot, Budsaba Rerkamnuaychoke, Pimjai Niparuck, Roongrudee Singdong, Adcharee Kongruang, Piyapha Hirunpatrawong, Thanaporn Siriyakorn, Pa-thai Yenchitsomanus, Teerapong Siriboonpiputtana
Publikováno v:
Journal of Mass Spectrometry and Advances in the Clinical Lab, Vol 28, Iss , Pp 122-132 (2023)
Introduction: The therapeutic strategy and management of chronic myeloid leukemia (CML) have rapidly improved with the discovery of effective tyrosine kinase inhibitors (TKIs) to target BCR::ABL1 oncoprotein. However, nearly 30% of patients develop T
Externí odkaz:
https://doaj.org/article/deeb276bbc80429799a9326590fbed06
Autor:
Adcharee Kongruang, Nittaya Limsuwanachot, Sutada Magmuang, Prapatsorn Areesirisuk, Pimjai Niparuck, Teerapong Siriboonpiputtana, Budsaba Rerkamnuaychoke
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjectives We performed a feasibility study of an FDA-approved commercial ddPCR assay to measure BCR::ABL1 in CML patients treated using TKI therapy.Methods Assay performance of standard RQ-PCR and commercially available FDA-approved ddPCR we
Externí odkaz:
https://doaj.org/article/74e82c1b45cc49ff8f6629a14e6185e8
Autor:
Smith Kungwankiattichai, Weerapat Owattanapanich, Thanawat Rattanathammethee, Ekarat Rattarittamrong, Chantiya Chanswangphuwana, Chantana Polprasert, Wasithep Limvorapitak, Supawee Saengboon, Pimjai Niparuck, Teeraya Puavilai, Jakrawadee Julamanee, Pirun Saelue, Chinadol Wanitpongpun, Kannadit Prayongratana, Chantarapa Sriswasdi, Chajchawan Nakhakes
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTIntroduction Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia (AML) with a unique clinical presentation and prognosis. This study aimed to investigate the epidemiology, clinical characteristics, treatments, a
Externí odkaz:
https://doaj.org/article/09b4fda50922456cb3e3a0c24e40292f
Autor:
Chantana Polprasert, Pimjai Niparuck, Thanawat Rattanathammethee, Sirorat Kobbuaklee, Theerin Lanamtieng, Ponlapat Rojnuckarin
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 1294-1297 (2022)
ABSTRACTIntroduction Risk stratification is essential for treatment decision in myelodysplastic neoplasms (MDS). Molecular international prognostic scoring system (M-IPSS) has been recently developed combining somatic mutations and clinical informati
Externí odkaz:
https://doaj.org/article/59d4a77f32e14aeb9930eb0abc44c570
Autor:
Naree Warnnissorn, Nonglak Kanitsap, Pimjai Niparuck, Paisarn Boonsakan, Prapasri Kulalert, Wasithep Limvorapitak, Lantarima Bhoopat, Supawee Saengboon, Pichika Chantrathammachart, Teeraya Puavilai, Suporn Chuncharunee
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 1237-1245 (2022)
Background Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma. The standard first-line therapy for DLBCL consists of rituximab cyclophosphamide doxorubicin vincristine and prednisone (R-CHOP). About 50–70% of patients may
Externí odkaz:
https://doaj.org/article/7a3587e67d3344bc84261152bbbe29ea
Autor:
Chantana Polprasert, Sunisa Kongkiatkamon, Pimjai Niparuck, Thanawat Rattanathammethee, Kitsada Wudhikarn, Suporn Chuncharunee, Sirorat Kobbuaklee, Amornchai Suksusut, Theerin Lanamtieng, Panisinee Lawasut, Thiti Asawapanumas, Udomsak Bunworasate, Ponlapat Rojnuckarin
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 765-771 (2022)
Introduction Myelodysplastic syndromes (MDS) predominantly present with varying degrees of cytopenia, while myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) exhibit proliferative features. Genetic defects underlying different complete
Externí odkaz:
https://doaj.org/article/d0d13dbfbf4647229388a86b42b55bc4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.